Lindis Bloodcare GmbH
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device (NCT06789224) | Lindis Bloodcare GmbH | 2022-02-15 |
Track Lindis Bloodcare GmbH automatically
Every clearance here is in the API, with alerts when new ones post.